- Unveiling the mechanism of action of nature-inspired anti-cancer compounds using a multi-omics approach
Nelson C. Soares et al, 2022, Journal of Proteomics CrossRef - Crosstalk between Ca2+ Signaling and Cancer Stemness: The Link to Cisplatin Resistance
Sana Kouba et al, 2022, IJMS CrossRef - Metformin Improves Ovarian Cancer Sensitivity to Paclitaxel and Platinum-Based Drugs: A Review of In Vitro Findings
Giovanni Tossetta, 2022, IJMS CrossRef - Role of RAS signaling in ovarian cancer
Lubna Therachiyil et al, 2022, F1000Res CrossRef - Immunogenic cell death-related gene landscape predicts the overall survival and immune infiltration status of ovarian cancer.
Wenwen Zhang et al, 2022, Front Genet CrossRef - A trans-Pt(ii) hedgehog pathway inhibitor complex with cytotoxicity towards breast cancer stem cells and triple negative breast cancer cells
Aisling L. Ryan et al, 2022, Dalton Trans. CrossRef - New progress of glutamine metabolism in the occurrence, development, and treatment of ovarian cancer from mechanism to clinic
Xiaojing Yang et al, 2022, Front. Oncol. CrossRef - Therapy-Induced Stromal Senescence Promoting Aggressiveness of Prostate and Ovarian Cancer
Elisa Pardella et al, 2022, Cells CrossRef - Targeting the NRF2/KEAP1 pathway in cervical and endometrial cancers
Giovanni Tossetta et al, 2023, European Journal of Pharmacology CrossRef - Identification of EMP1 as a critical gene for cisplatin resistance in ovarian cancer by using integrated bioinformatics analysis
Qingsong Zeng et al, 2023, Cancer Medicine CrossRef - Cancer cell cycle heterogeneity as a critical determinant of therapeutic resistance
Ebrahim H. Maleki et al, 2023, Genes & Diseases CrossRef - Synthesis, Characterization and Biological Investigation of the Platinum(IV) Tolfenamato Prodrug–Resolving Cisplatin-Resistance in Ovarian Carcinoma Cell Lines
Marie-Christin Barth et al, 2023, IJMS CrossRef - Sustained delivery of PARP inhibitor Talazoparib for the treatment of BRCA-deficient ovarian cancer
Shicheng Yang et al, 2023, Front. Oncol. CrossRef - Differential molecular pathway expression according to chemotherapeutic response in ovarian clear cell carcinoma
Min Yin et al, 2023, BMC Women's Health CrossRef - A biscarbene gold(I)-NHC-complex overcomes cisplatin-resistance in A2780 and W1 ovarian cancer cells highlighting pERK as regulator of apoptosis
Philipp König et al, 2023, Cancer Chemother Pharmacol CrossRef - Aberrant epigenetic regulation of FZD3 by TET2 is involved in ovarian cancer cell resistance to cisplatin
Li Zhu et al, 2023, Journal of Chemotherapy CrossRef - Mechanisms of autophagy and endoplasmic reticulum stress in the reversal of platinum resistance of epithelial ovarian cancer cells by naringin
Jun Zhu et al, 2023, Mol Biol Rep CrossRef - Targeting the stimulator of interferon genes (STING) in breast cancer
Ma Ying-Rui et al, 2023, Front. Pharmacol. CrossRef - Scutellaria baicalensis Georgi and Their Natural Flavonoid Compounds in the Treatment of Ovarian Cancer: A Review
Jiaying Cai et al, 2023, Molecules CrossRef - Potentiation of Cisplatin Cytotoxicity in Resistant Ovarian Cancer SKOV3/Cisplatin Cells by Quercetin Pre-Treatment
Aseel Ali Hasan et al, 2023, IJMS CrossRef - Single-cell RNA sequencing reveals a pro-metastatic subpopulation and the driver transcription factor NFE2L1 in ovarian cancer cells
Junseong Park et al, 2023, Genes Genom CrossRef - Chemotherapy‐induced release of ADAM17 bearing EV as a potential resistance mechanism in ovarian cancer
Gerrit Hugendieck et al, 2023, J of Extracellular Vesicle CrossRef - Development and Perspectives: Multifunctional Nucleic Acid Nanomedicines for Treatment of Gynecological Cancers
Tetiana Korzun et al, 2023, Small CrossRef - Glucose-6-phosphate dehydrogenase: a therapeutic target for ovarian cancer
Chenxi Wang et al, 2023, Expert Opinion on Therapeutic Targets CrossRef - Enzymatically crosslinked magnetic starch-grafted poly(tannic acid) hydrogel for “smart” cancer treatment: An in vitro chemo/hyperthermia therapy study
Morteza Eskandani et al, 2023, International Journal of Biological Macromolecules CrossRef - Snail transcription factors as key regulators of chemoresistance, stemness and metastasis of ovarian cancer cells
Michal Kielbik et al, 2023, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef - Nano-curcumin formulations for targeted therapy of colorectal cancer
Hossein Shahdadi Sardou et al, 2023, Journal of Drug Delivery Science and Technology CrossRef - Auranofin Induces Lethality Driven by Reactive Oxygen Species in High-Grade Serous Ovarian Cancer Cells
Farah H. Abdalbari et al, 2023, Cancers CrossRef - Meta‐analysis of microarray data to determine gene indicators involved in the cisplatin resistance in ovarian cancer
Somayeh Hashemi Sheikhshabani et al, 2023, Cancer Reports CrossRef - PINK1-PTEN axis promotes metastasis and chemoresistance in ovarian cancer via non-canonical pathway
Fang Zheng et al, 2023, J Exp Clin Cancer Res CrossRef - Does the addition of metformin to carboplatin treatment decreases ovarian reserve damage associated with carboplatin usage?
Sevgi Ayhan et al, 2023, J Ovarian Res CrossRef - CT radiomics prediction of CXCL9 expression and survival in ovarian cancer
Rui Gu et al, 2023, J Ovarian Res CrossRef - Mitophagy-related long non-coding RNA signature predicts prognosis and drug response in Ovarian Cancer.
Jiao Wang et al, 2023, J Ovarian Res CrossRef - CD39+MDSC Facilitates Cisplatin Resistance of Ovarian Cancer Cells by
Affecting Adenosine Synthesis
Jiong Ma et al, 2023, CPD CrossRef - The microbiome and ovarian cancer: insights, implications, and therapeutic opportunities
Yogita Mehra et al, 2023, J Cancer Metastasis Treat CrossRef - null
Andrea Cuschieri et al, 2023 CrossRef - Beyond Sterilization: A Comprehensive Review on the Safety and Efficacy of Opportunistic Salpingectomy as a Preventative Strategy for Ovarian Cancer
Tahereh Zadabedini Masouleh et al, 2023, Current Oncology CrossRef - The impact of PARP inhibitors in the whole scenario of Ovarian Cancer management: a Systematic Review and Network Meta-Analysis
Nicoletta Staropoli et al, 2023, Critical Reviews in Oncology/Hematology CrossRef - Deep learning enhanced the diagnostic merit of serum glycome for multiple cancers
Haobo Zhang et al, 2024, iScience CrossRef - A benzimidazolium salt induces apoptosis and arrests cells at sub-G1 phase in epithelial ovarian cancer cells
Sakine Akar et al, 2024, Mol Biol Rep CrossRef - Trps1 predicts poor prognosis in advanced high grade serous ovarian carcinoma
Xiaojiang Wang et al, 2024, Intl Journal of Cancer CrossRef - Methylene Blue Metabolic Therapy Restrains In Vivo Ovarian Tumor Growth
Jorgelindo da Veiga Moreira et al, 2024, Cancers CrossRef - Combined radiomics-clinical model to predict platinum-sensitivity in advanced high-grade serous ovarian carcinoma using multimodal MRI
Inye Na et al, 2024, Front. Oncol. CrossRef - ITGB2 fosters the cancerous characteristics of ovarian cancer cells through its role in mitochondrial glycolysis transformation
Li Guo-Wei et al, 2024, Aging CrossRef - Upregulation of CALD1 predicted a poor prognosis for platinum-treated ovarian cancer and revealed it as a potential therapeutic resistance target
Wei Li et al, 2024, BMC Genomics CrossRef - null
Katie E. Allen et al, 2023 CrossRef - HMGB1 enhances the migratory and invasive abilities of A2780/DDP cells by facilitating epithelial to mesenchymal transition via GSK‑3β
Jinhua Wang et al, 2024, Exp Ther Med CrossRef - Hsa_circ_0000585 promotes chemoresistance to cis-platin in epithelial cells of ovarian cancer by modulating autophagy
Pei Du et al, 2023, Biochemical and Biophysical Research Communications CrossRef - Apurinic/apyrimidinic endodeoxyribonuclease 1 (APE1) promotes stress granule formation via YBX1 phosphorylation in ovarian cancer
Shuyu Mao et al, 2024, Cell. Mol. Life Sci. CrossRef - Refining molecular subtypes and risk stratification of ovarian cancer through multi‐omics consensus portfolio and machine learning
Jing Zhang et al, 2024, Environmental Toxicology CrossRef - Enhancing precision medicine: a nomogram for predicting platinum resistance in epithelial ovarian cancer
Ruyue Li et al, 2024, World J Surg Onc CrossRef - A Stem-like Patient-Derived Ovarian Cancer Model of Platinum Resistance Reveals Dissociation of Stemness and Resistance
Tise Suzuki et al, 2024, IJMS CrossRef - Photo-responsive doxorubicin delivery: Nanogel systems based on azobenzene and host-guest interactions enhanced by squeezing action
Samaneh Yousefi Adlsadabad et al, 2024, Polymer CrossRef - Exploring the Antiproliferative and Modulatory Effects of 1-Methoxyisobrassinin on Ovarian Cancer Cells: Insights into Cell Cycle Regulation, Apoptosis, Autophagy, and Its Interactions with NAC
Martina Zigová et al, 2024, Molecules CrossRef - Therapeutic strategies targeting folate receptor α for ovarian cancer
Jia Mai et al, 2023, Front. Immunol. CrossRef - TCEB3 initiates ovarian cancer apoptosis by mediating ubiquitination and degradation of MCL‐1
Ying Cai et al, 2024, The FASEB Journal CrossRef - Deciphering the Molecular Mechanisms behind Drug Resistance in Ovarian Cancer to Unlock Efficient Treatment Options
Mariana Nunes et al, 2024, Cells CrossRef - Iron promotes ovarian cancer malignancy and advances platinum resistance by enhancing DNA repair via FTH1/FTL/POLQ/RAD51 axis
Qingyu Zhang et al, 2024, Cell Death Dis CrossRef - Targeting ferroptosis in ovarian cancer: Novel strategies to overcome chemotherapy resistance
Celine Kapper et al, 2024, Life Sciences CrossRef - CD276 enhances sunitinib resistance in clear cell renal cell carcinoma by promoting DNA damage repair and activation of FAK-MAPK signaling pathway
Zhi-yu Zhang et al, 2024, BMC Cancer CrossRef - The role of chaperone-mediated autophagy in drug resistance
Ana Beatriz da Silva Teixeira et al, 2024, Genet. Mol. Biol. CrossRef - Dual‑regulated oncolytic adenovirus carrying ERCC1‑siRNA gene possesses potent antitumor effect on ovarian cancer cells
Ting Zhao et al, 2024, Mol Med Rep CrossRef - Effects of metformin on cancers in experimental and clinical studies: Focusing on autophagy and AMPK/mTOR signaling pathways
Mohammad Yasin Zamanian et al, 2024, Cell Biochemistry & Function CrossRef - Lactate drives the ESM1–SCD1 axis to inhibit the antitumor CD8+ T-cell response by activating the Wnt/β-catenin pathway in ovarian cancer cells and inducing cisplatin resistance
Zhiwen Fan et al, 2024, International Immunopharmacology CrossRef - MAFF Mediates PEITC-induced Enhancement of Sensitivity to Carboplatin in Ovarian Cancer Cell Lines via Activating ZNF711 Transcription in vivo and in vitro
Meng Luan et al, 2024, Chemico-Biological Interactions CrossRef - RNA-binding protein THUMPD2 inhibits proliferation and promotes metastasis in epithelial ovarian cancer
Minhui Hua et al, 2024, Heliyon CrossRef - Exosomal miR-4516 derived from ovarian cancer stem cells enhanced cisplatin tolerance in ovarian cancer by inhibiting GAS7
Xin Pan et al, 2024, Gene CrossRef - Mirvetuximab after anaphylaxis to Paclitaxel: A case report
Megan A. Stewart et al, 2024, Gynecologic Oncology Reports CrossRef - The Induction of G2/M Phase Cell Cycle Arrest and Apoptosis by the Chalcone Derivative 1C in Sensitive and Resistant Ovarian Cancer Cells Is Associated with ROS Generation
Šimon Salanci et al, 2024, IJMS CrossRef - Comprehensive analysis of hub genes associated with cisplatin-resistance in ovarian cancer and screening of therapeutic drugs through bioinformatics and experimental validation
Yunshan Zhu et al, 2024, J Ovarian Res CrossRef - KDM1A/LSD1 inhibition enhances chemotherapy response in ovarian cancer
Yihong Chen et al, 2024, Molecular Carcinogenesis CrossRef - A novel Ni-based complex inducing apoptosis through mitochondrial dysfunction in osteosarcoma HOS cells
Xiao-Dong Liu et al, 2024, New J. Chem. CrossRef - Acetylation model predicts prognosis of patients and affects immune microenvironment infiltration in epithelial ovarian carcinoma
Xuan Wang et al, 2024, J Ovarian Res CrossRef - Platinum-based chemotherapy: trends in organic nanodelivery systems
João A. V. Santos et al, 2024, Nanoscale CrossRef - Related Clinical Factors of Platinum-Based Chemotherapy Resistance in Patients with Epithelial Ovarian Cancer
Zhuo Xiong et al, 2024, Gynecol Obstet Invest CrossRef - Identification and Comprehensive Analysis of circRNA-miRNA-mRNA Regulatory Networks in A2780 Cells Treated with Resveratrol
Weihua Zhu et al, 2024, Genes CrossRef - Role of NRF2 in Ovarian Cancer
Giovanni Tossetta et al, 2022, Antioxidants CrossRef - A Predictive Model for Initial Platinum‐Based Chemotherapy Efficacy in Patients with Postoperative Epithelial Ovarian Cancer Using Tissue‐Derived Small Extracellular Vesicles
Shizhen Shen et al, 2024, J of Extracellular Vesicle CrossRef - CACNA1H restrains chemotherapy resistance in ovarian clear cell carcinoma cells by repressing autophagy
Huaijing Shi et al, 2024, Mol Genet Genomics CrossRef - Molecular mechanisms of cisplatin resistance in ovarian cancer
Chenying Jiang et al, 2024, Genes & Diseases CrossRef - Metformin combined with cisplatin reduces anticancer activity via ATM/CHK2-dependent upregulation of Rad51 pathway in ovarian cancer
Jingjing Zhang et al, 2024, Neoplasia CrossRef - Effects of curcumin nanoparticles on the proliferation and migration of human ovarian cancer cells assessed through the NF-κB/PRL-3 signaling pathway
Shuyan Liu et al, 2024, International Immunopharmacology CrossRef - Salvia microphylla essential oil reduces cell viability in cisplatin-resistant clear cell type ovarian cancer cells caused by mitochondrial dysfunction
Hyewon Jang et al, 2024, Mol. Cell. Toxicol. CrossRef - Application of single cell sequencing technology in ovarian cancer research (review)
Qiqolei Yuan et al, 2024, Funct Integr Genomics CrossRef - ALDH and cancer stem cells: Pathways, challenges, and future directions in targeted therapy.
Kousalya Lavudi et al, 2024, Life Sci CrossRef - Knocking down RAD51AP1 enhances chemosensitivity by inhibiting the self-renewal of CD133 positive ovarian cancer stem-like cells
Si-heng Zeng et al, 2024, Discov Onc CrossRef - Quantifying Intracellular Platinum Accumulation Using Inductively Coupled Mass Spectrometry
Arun Krishnaraj et al, 2024, Current Protocols CrossRef - Unveiling the impact of cell death-related genes and immune dynamics on drug resistance in lung adenocarcinoma: a risk score model and functional insights
Yuanyuan Xiao et al, 2024, Discov Onc CrossRef - Progress in Research of Nanotherapeutics for Overcoming Multidrug Resistance in Cancer
Ayitila Maimaitijiang et al, 2024, IJMS CrossRef - KLF4 activates LATS2 to promote cisplatin sensitivity in ovarian cancer through DNA damage
Ling Ma et al, 2024 CrossRef - ADC: a deadly killer of platinum resistant ovarian cancer
Xu Cheng et al, 2024, J Ovarian Res CrossRef - DCAF13 promotes ovarian cancer progression by activating FRAS1-mediated FAK signaling pathway
Ze-Yi Tang et al, 2024, Cell. Mol. Life Sci. CrossRef - In Vitro Methylene Blue and Carboplatin Combination Triggers Ovarian Cancer Cells Death
Jorgelindo da Veiga Moreira et al, 2024, IJMS CrossRef - Targeting Mitochondrial Cholesterol Efflux via TCF21/ABCA10 Pathway to Enhance Cisplatin Efficacy in Ovarian Cancer
Li Li et al, 2024, Biochem Genet CrossRef - Folate Receptor Alpha—A Secret Weapon in Ovarian Cancer Treatment?
Karol Bukowski et al, 2024, IJMS CrossRef - CRISPR/Cas9 system: a novel approach to overcome chemotherapy and radiotherapy resistance in cancer
Somaye Noruzi et al, 2024, Naunyn-Schmiedeberg's Arch Pharmacol CrossRef - Beyond tumor‑associated macrophages involved in spheroid formation and dissemination: Novel insights for ovarian cancer therapy (Review)
Yuchen Liu et al, 2024, Int J Oncol CrossRef - KLF4 promotes cisplatin resistance by activating mTORC1 signaling in ovarian cancer
Wanzhen Zhou et al, 2024, Discov Onc CrossRef - A Multi-View Contrastive Learning and Semi-Supervised Self-Distillation Framework for Early Recurrence Prediction in Ovarian Cancer
Chi Dong et al, 2024, Computerized Medical Imaging and Graphics CrossRef - Responsive boronate ester lipid nanoparticles for enhanced delivery of veliparib and platinum (IV) prodrug in chemotherapy
Wanyue Xiao et al, 2024, Journal of Colloid and Interface Science CrossRef - Development of a Prognostic Risk Model Based on Oxidative Stress-related Genes for Platinum-resistant Ovarian Cancer Patients
Huishan Su et al, 2025, PRA CrossRef - Unraveling the Role of Ubiquitin-Conjugating Enzyme UBE2T in Tumorigenesis: A Comprehensive Review
Chang Gao et al, 2024, Cells CrossRef - Opportunities for predictive proteogenomic biomarkers of drug treatment sensitivity in epithelial ovarian cancer
Trudy J. Philips et al, 2025, Front. Oncol. CrossRef - CT-based radiomics predicts HRD score and HRD status in patients with ovarian cancer
Yujiao Wu et al, 2025, Front. Oncol. CrossRef - LncRNA MIR17HG drives cisplatin resistance partially via miR-138-5p/AKAP9 axis in cholangiocarcinoma
Lingyu Tang et al, 2025, Scandinavian Journal of Gastroenterology CrossRef